| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SCRT2 HIVEP2 SALL3 SOX8 DBP RREB1 KDM6B HOXA10 NKX2-8 SAFB NFKB2 PITX1 NKX2-2 ZNF319 FOXO6 KLF15 E2F2 GTF2IRD1 RFX2 ZNF865 ZNF768 AR SIRT1 ZBTB14 ZBTB45 MTOR PROX2 OLIG2 | 5.43e-05 | 1271 | 197 | 28 | GO:0000987 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TPR MAPT NCK1 BCL3 BCL9 SRCAP ZZEF1 TRIM55 HDGFL2 ZNF541 PML MAPK8IP1 ANK3 RETREG2 SH2B2 AR SIRT1 AKAP12 SPTBN4 YEATS2 G3BP1 TLE1 TLE2 FIZ1 SPEN SMAD7 | 7.77e-05 | 1160 | 197 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | tubulin binding | TPR KIF1A MAP1B MAPT APC2 SPAG8 STIM1 HAUS8 BRCA2 STARD9 DIP2B MACF1 CEP295 HTT | 9.44e-05 | 428 | 197 | 14 | GO:0015631 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SCRT2 HIVEP2 SALL3 SOX8 DBP RREB1 KDM6B HOXA10 NKX2-8 SAFB NFKB2 PITX1 NKX2-2 ZNF319 FOXO6 KLF15 E2F2 GTF2IRD1 RFX2 ZNF865 ZNF768 AR SIRT1 ZBTB14 ZBTB45 PROX2 OLIG2 | 9.59e-05 | 1244 | 197 | 27 | GO:0000978 |
| GeneOntologyMolecularFunction | calcitonin receptor binding | 9.68e-05 | 2 | 197 | 2 | GO:0031716 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TPR MAPT NCK1 BCL3 BCL9 SRCAP ZZEF1 TRIM55 HDGFL2 ZNF541 PML MAPK8IP1 ANK3 RETREG2 SGTA SH3KBP1 SH2B2 AR SIRT1 AKAP12 SPTBN4 YEATS2 G3BP1 TLE1 TLE2 FIZ1 SPEN SMAD7 | 1.64e-04 | 1356 | 197 | 28 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SCRT2 ZHX3 HIVEP2 SALL3 SOX8 DBP RREB1 KDM6B CIC HOXA10 NKX2-8 SAFB NFKB2 PITX1 NKX2-2 ZNF319 FOXO6 KLF15 E2F2 GTF2IRD1 RFX2 ZNF865 ZNF768 AR SIRT1 ZBTB14 ZBTB45 PROX2 OLIG2 | 2.36e-04 | 1459 | 197 | 29 | GO:0000977 |
| GeneOntologyMolecularFunction | phosphatidate cytidylyltransferase activity | 2.89e-04 | 3 | 197 | 2 | GO:0004605 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 3.73e-04 | 134 | 197 | 7 | GO:0003697 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR KIF1A MAP1B MAPT APC2 OBSCN SPAG8 STIM1 HAUS8 BRCA2 STARD9 MAPK8IP1 DIP2B RPH3AL ANK3 LMTK2 TRIOBP SPTBN4 MACF1 CEP295 SAMD14 MYO16 HTT | 5.45e-04 | 1099 | 197 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SCRT2 ZHX3 HIVEP2 SALL3 SOX8 DBP RREB1 CIC CREBZF HOXA10 NKX2-8 NFKB2 PITX1 NKX2-2 ZNF319 FOXO6 KLF15 E2F2 GTF2IRD1 RFX2 SP110 ZNF768 AR ZBTB14 ZBTB45 PROX2 OLIG2 | 7.16e-04 | 1412 | 197 | 27 | GO:0000981 |
| GeneOntologyMolecularFunction | microtubule binding | 1.00e-03 | 308 | 197 | 10 | GO:0008017 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.04e-03 | 206 | 197 | 8 | GO:0140030 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-lysine acetylation | 3.61e-06 | 12 | 195 | 4 | GO:2000756 | |
| GeneOntologyBiologicalProcess | regulation of protein acetylation | 5.91e-06 | 28 | 195 | 5 | GO:1901983 | |
| GeneOntologyCellularComponent | Bcl3/NF-kappaB2 complex | 8.66e-05 | 2 | 195 | 2 | GO:0033257 | |
| GeneOntologyCellularComponent | microtubule | KIF1A MAP1B MAPT APC2 SPAG8 STIM1 HAUS8 TRIM55 NAV1 RADIL GRAMD2B MACF1 CEP295 LZTS2 CEP170B | 1.51e-04 | 533 | 195 | 15 | GO:0005874 |
| Domain | PC_trans | 1.07e-04 | 2 | 194 | 2 | IPR000374 | |
| Domain | MeTrfase_trithorax | 1.07e-04 | 2 | 194 | 2 | IPR016569 | |
| Domain | Calcitonin_gene-rel_peptide | 1.07e-04 | 2 | 194 | 2 | IPR015476 | |
| Domain | PC_Trfase_euk | 1.07e-04 | 2 | 194 | 2 | IPR016720 | |
| Domain | CDS | 1.07e-04 | 2 | 194 | 2 | PS01315 | |
| Domain | SMAD_FHA_domain | 2.01e-04 | 52 | 194 | 5 | IPR008984 | |
| Domain | - | KMT2B BARD1 FYCO1 PJA2 TRIM55 KMT2A PML RPH3AL PHRF1 RNF149 SP110 PIKFYVE GTF2E1 RNF146 | 2.62e-04 | 449 | 194 | 14 | 3.30.40.10 |
| Domain | Calcitonin_peptide-like | 3.20e-04 | 3 | 194 | 2 | IPR001693 | |
| Domain | CALCITONIN | 3.20e-04 | 3 | 194 | 2 | SM00113 | |
| Domain | CALCITONIN | 3.20e-04 | 3 | 194 | 2 | PS00258 | |
| Domain | Calcitonin-like | 3.20e-04 | 3 | 194 | 2 | IPR021117 | |
| Domain | Calcitonin_CS | 3.20e-04 | 3 | 194 | 2 | IPR018360 | |
| Domain | Znf_RING/FYVE/PHD | KMT2B BARD1 FYCO1 PJA2 TRIM55 KMT2A PML RPH3AL PHRF1 RNF149 SP110 PIKFYVE GTF2E1 RNF146 | 3.27e-04 | 459 | 194 | 14 | IPR013083 |
| Domain | SH3 | 4.40e-04 | 216 | 194 | 9 | PS50002 | |
| Domain | SH3_domain | 5.03e-04 | 220 | 194 | 9 | IPR001452 | |
| Domain | - | 5.13e-04 | 36 | 194 | 4 | 2.60.200.20 | |
| Domain | FHA_dom | 5.13e-04 | 36 | 194 | 4 | IPR000253 | |
| Domain | Znf_FYVE_PHD | 8.77e-04 | 147 | 194 | 7 | IPR011011 | |
| Domain | FYrich_C | 1.05e-03 | 5 | 194 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.05e-03 | 5 | 194 | 2 | IPR003888 | |
| Domain | FYRC | 1.05e-03 | 5 | 194 | 2 | SM00542 | |
| Domain | FYRN | 1.05e-03 | 5 | 194 | 2 | SM00541 | |
| Domain | Groucho_enhance | 1.05e-03 | 5 | 194 | 2 | IPR009146 | |
| Domain | Calc_CGRP_IAPP | 1.05e-03 | 5 | 194 | 2 | PF00214 | |
| Domain | TLE_N | 1.05e-03 | 5 | 194 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 1.05e-03 | 5 | 194 | 2 | IPR005617 | |
| Domain | Calcitonin/adrenomedullin | 1.05e-03 | 5 | 194 | 2 | IPR021116 | |
| Domain | FYRN | 1.05e-03 | 5 | 194 | 2 | PF05964 | |
| Domain | FYRC | 1.05e-03 | 5 | 194 | 2 | PF05965 | |
| Domain | FYRC | 1.05e-03 | 5 | 194 | 2 | PS51543 | |
| Domain | FYRN | 1.05e-03 | 5 | 194 | 2 | PS51542 | |
| Domain | SH3_9 | 1.31e-03 | 78 | 194 | 5 | PF14604 | |
| Pathway | WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING | 1.50e-05 | 6 | 130 | 3 | M39742 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 HIVEP2 KMT2B PCNX3 OBSCN C15orf39 FYCO1 KDM6B BCL9 SRCAP ZZEF1 STK11IP CIC PPP1R26 TNRC18 ZNF276 NFKB2 PITX1 NAV1 LRRC56 DNMBP PLK3 CRYBG2 LMTK2 HUWE1 GTF2IRD1 ZNF865 SH2B2 PIKFYVE UNC119 NHSL1 RADIL IGF1R AATK MTOR KANK3 DUSP16 TNKS1BP1 SPEN CEP170B HTT SMAD7 TJP3 | 1.64e-23 | 1105 | 200 | 43 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP2 MAP1B MAPT ANKRD27 CIC STIM1 HAUS8 PJA2 STARD9 TBC1D1 NAV1 KMT2A DNMBP PML DIP2B LMTK2 AKT1S1 UNC119 NHSL1 RADIL IGF1R FAM171A2 MTOR ARHGEF1 MACF1 TNKS1BP1 NUB1 CEP170B SNX2 | 2.15e-14 | 861 | 200 | 29 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR ZHX3 KMT2B MAPT RREB1 BCL9 CIC SAFB KMT2A DNMBP DIP2B SEC16B SGTA PHRF1 FNBP4 HUWE1 GTF2IRD1 CHAMP1 ZNF768 AKT1S1 SIRT1 YEATS2 G3BP1 EIF4G2 TNKS1BP1 SPEN SNX2 | 8.03e-14 | 774 | 200 | 27 | 15302935 |
| Pubmed | TPR GAK SERBP1 KMT2B MAP1B NCK1 SRCAP KMT2A ANK3 FNBP4 SMC4 HUWE1 CHAMP1 YEATS2 UBE2O TNKS1BP1 QSER1 LZTS2 SPEN SNX2 HTT | 1.01e-11 | 549 | 200 | 21 | 38280479 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDS1 HIVEP2 KIF1A MAP1B MAPT OBSCN BARD1 ZNF462 TNRC18 TBC1D1 NAV1 DIP2B RPH3AL ANK3 SGTA FNBP4 TRIOBP HUWE1 TARS2 GTF2IRD1 TMEM255B AR SPTBN4 YEATS2 IGF1R MACF1 QSER1 LZTS2 CEP170B SNX2 HTT | 5.75e-10 | 1489 | 200 | 31 | 28611215 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | GAK C15orf39 SRCAP CIC BRCA2 NFKB2 NAV1 DNMBP PML E2F2 HUWE1 SIRT1 PIKFYVE YEATS2 MACF1 TNKS1BP1 LZTS2 SPEN CEP170B | 1.69e-09 | 588 | 200 | 19 | 38580884 |
| Pubmed | TPR KMT2B C15orf39 SOX8 RREB1 CIC ZNF462 BRCA2 NAV1 HUWE1 CHAMP1 YEATS2 FAM193A TLE1 FIZ1 TNKS1BP1 | 3.22e-09 | 418 | 200 | 16 | 34709266 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KMT2B BARD1 RREB1 SRCAP CIC HOXA10 PRDM11 SAFB ZNF276 PITX1 KMT2A ZNF319 HDGFL2 PHRF1 FNBP4 NOL9 ZFC3H1 GTF2IRD1 CHAMP1 SP110 ZNF768 ZBTB14 YEATS2 FIZ1 EIF4G2 QSER1 SPEN | 7.98e-09 | 1294 | 200 | 27 | 30804502 |
| Pubmed | TPR APC2 FYCO1 BCL9 ZNF462 PLCB1 NAV1 MAPK8IP1 DIP2B ANK3 SH3KBP1 TRIOBP NOL9 HUWE1 AKAP12 SPTBN4 UBE2O FAM171A2 G3BP1 MTOR MACF1 QSER1 CEP170B | 9.71e-09 | 963 | 200 | 23 | 28671696 | |
| Pubmed | TPR SERBP1 MAP1B MAPT NACAD STIM1 PJA2 TNRC18 SAFB PLCB1 NAV1 MAPK8IP1 ANK3 RETREG2 SH3KBP1 LMTK2 TRIOBP HUWE1 NHSL1 UBE2O FAM171A2 G3BP1 EIF4G2 MACF1 CEP170B | 1.12e-08 | 1139 | 200 | 25 | 36417873 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ZHX3 HIVEP2 SOX8 DBP RREB1 CIC CREBZF NKX2-8 NFKB2 PITX1 KMT2A NKX2-2 ZNF541 KLF15 E2F2 RFX2 SP110 AR ZBTB14 YEATS2 PROX2 OLIG2 | 1.61e-08 | 908 | 200 | 22 | 19274049 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZHX3 KMT2B BARD1 RREB1 SRCAP CIC ZNF462 HOXA10 PITX1 KMT2A HDGFL2 RAD23A CHAMP1 SIRT1 GTF2E1 UBE2O QSER1 SPEN | 1.78e-08 | 608 | 200 | 18 | 36089195 |
| Pubmed | Interaction network of human early embryonic transcription factors. | HIVEP2 KMT2B C15orf39 RREB1 BCL9 ZNF462 TNRC18 PITX1 KMT2A SIRT1 ZBTB14 TLE1 QSER1 SPEN | 1.91e-08 | 351 | 200 | 14 | 38297188 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | HIVEP2 BARD1 SOX8 DBP CIC HOXA10 ZNF276 BRCA2 NFKB2 NKX2-2 PML E2F2 RFX2 SP110 ZNF768 AR SIRT1 GTF2E1 TLE1 TLE2 SPEN | 4.26e-08 | 877 | 200 | 21 | 20211142 |
| Pubmed | ABCA2 KDM6B ZZEF1 NACAD ANKRD27 HPS4 PLCB1 DNMBP PHRF1 FNBP4 LMTK2 TRIOBP CHAMP1 UBE2O TNKS1BP1 LZTS2 | 8.50e-08 | 529 | 200 | 16 | 14621295 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ZHX3 GAK SERBP1 MAP1B SRCAP CIC SAFB KMT2A HDGFL2 PML CHAMP1 AKAP12 YEATS2 GTF2E1 UBE2O FAM193A G3BP1 EIF4G2 MACF1 TNKS1BP1 | 1.22e-07 | 934 | 200 | 21 | 33916271 |
| Pubmed | 1.31e-07 | 9 | 200 | 4 | 26671463 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ZHX3 SERBP1 SALL3 MAP1B RREB1 CIC PRAM1 SAFB BRCA2 KMT2A HDGFL2 PML TCEA2 FNBP4 CHAMP1 YEATS2 G3BP1 EIF4G2 QSER1 SPEN | 1.73e-07 | 954 | 200 | 21 | 36373674 |
| Pubmed | 1.87e-07 | 3 | 200 | 3 | 27356871 | ||
| Pubmed | ZHX3 MAPT C15orf39 BCL9 TFG CIC SAFB PITX1 KMT2A HDGFL2 PHRF1 FNBP4 SIRT1 GTF2E1 | 2.01e-07 | 425 | 200 | 14 | 24999758 | |
| Pubmed | ZHX3 KMT2B C15orf39 RREB1 BCL9 SRCAP CIC ZNF462 HOXA10 NFKB2 PITX1 KMT2A ZNF319 PML MRPS18B SH3KBP1 KLF15 ZNF768 SIRT1 ZBTB14 YEATS2 UBE2O G3BP1 TLE1 QSER1 SPEN | 2.28e-07 | 1429 | 200 | 26 | 35140242 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | SERBP1 KMT2B NCK1 KDM6B NACAD CIC SAFB RAD23A RETREG2 SGTA DUSP8 SH3KBP1 ZC3HC1 SP110 ZNF768 AKT1S1 AKAP12 SPTBN4 UNC119 MTOR TLE1 ARHGEF1 | 6.32e-07 | 1124 | 200 | 22 | 21900206 |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 1.44e-06 | 186 | 200 | 9 | 33637726 | |
| Pubmed | SERBP1 MAP1B MAPT CIC ZC3HC1 HUWE1 AKT1S1 AKAP12 TNKS1BP1 SAMD14 | 1.81e-06 | 246 | 200 | 10 | 15345747 | |
| Pubmed | KMT2B ZZEF1 ANKRD27 CREBZF PPP1R26 CISH TBC1D1 PPP1R37 ANK3 FNBP4 HUWE1 EIF4G2 MACF1 LZTS2 SMAD7 | 1.95e-06 | 591 | 200 | 15 | 15231748 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | SCRT2 SOX8 DBP HOXA10 NKX2-8 ZNF276 NFKB2 PITX1 KLF15 E2F2 RFX2 ZBTB14 ZBTB45 OLIG2 | 3.69e-06 | 544 | 200 | 14 | 28473536 |
| Pubmed | 3.70e-06 | 6 | 200 | 3 | 27008179 | ||
| Pubmed | 3.70e-06 | 6 | 200 | 3 | 22696681 | ||
| Pubmed | 3.76e-06 | 209 | 200 | 9 | 36779422 | ||
| Pubmed | ZHX3 HIVEP2 KIF1A CIC ZNF462 HOXA10 ZNF276 KMT2A E2F2 GTF2IRD1 CHAMP1 ZBTB14 PIKFYVE RNF146 PROX2 MACF1 | 3.96e-06 | 709 | 200 | 16 | 22988430 | |
| Pubmed | GAK STIM1 PJA2 ZNHIT2 HDGFL2 PML RAD23A ANK3 MRPS18B SGTA FNBP4 TRIOBP NOL9 ZFC3H1 TARS2 SIRT1 AKAP12 UBE2O FAM193A FAM171A2 EIF4G2 MACF1 LZTS2 SNX2 | 5.45e-06 | 1487 | 200 | 24 | 33957083 | |
| Pubmed | GAK NCK1 RREB1 TFG HAUS8 NAV1 RNF149 HUWE1 PIKFYVE YEATS2 UBE2O FAM193A TLE1 CEP295 NUB1 QSER1 | 6.02e-06 | 733 | 200 | 16 | 34672954 | |
| Pubmed | MAP1B MAPT CDS2 PLCB1 SH3KBP1 RADIL MACF1 TNKS1BP1 SAMD14 CEP170B HTT | 6.04e-06 | 347 | 200 | 11 | 17114649 | |
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 6.36e-06 | 223 | 200 | 9 | 33187986 | |
| Pubmed | TPR SERBP1 KIF1A MAP1B KMT2A PHRF1 SMC4 NOL9 HUWE1 UBE2O G3BP1 MTOR MACF1 TNKS1BP1 SPEN | 6.49e-06 | 653 | 200 | 15 | 22586326 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SERBP1 KIF1A SPAG8 LMTK2 MUC16 ZBTB14 IGF1R AATK G3BP1 DUSP16 EIF4G2 SPEN | 6.54e-06 | 420 | 200 | 12 | 28065597 |
| Pubmed | ZHX3 KMT2B C15orf39 RREB1 BCL9 CIC PRAM1 TNRC18 SAFB PITX1 KMT2A PML RAD23A SMC4 SIRT1 YEATS2 G3BP1 EIF4G2 QSER1 SPEN | 6.56e-06 | 1103 | 200 | 20 | 34189442 | |
| Pubmed | TPR GAK SERBP1 SAFB PML TRIOBP AKAP12 ARHGEF1 MACF1 TNKS1BP1 SNX2 | 8.54e-06 | 360 | 200 | 11 | 33111431 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | SERBP1 BARD1 SAFB TBC1D1 PML SAMHD1 NOL9 CHAMP1 ZNF768 SIRT1 UNC119 UBE2O G3BP1 MTOR NUB1 | 8.80e-06 | 670 | 200 | 15 | 22990118 |
| Pubmed | 9.29e-06 | 49 | 200 | 5 | 31762063 | ||
| Pubmed | 1.09e-05 | 130 | 200 | 7 | 12421765 | ||
| Pubmed | 1.15e-05 | 87 | 200 | 6 | 12465718 | ||
| Pubmed | 1.17e-05 | 304 | 200 | 10 | 32235678 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | SERBP1 ZZEF1 TFG DNMBP HDGFL2 RAD23A SGTA SMC4 ZC3HC1 SAMHD1 HUWE1 AKT1S1 SIRT1 AKAP12 GTF2E1 UBE2O G3BP1 MTOR ARHGEF1 MACF1 TNKS1BP1 SNX2 HTT | 1.21e-05 | 1455 | 200 | 23 | 22863883 |
| Pubmed | 1.53e-05 | 9 | 200 | 3 | 25370275 | ||
| Pubmed | Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression. | 1.53e-05 | 9 | 200 | 3 | 16951254 | |
| Pubmed | Molecular characterization of ENU mouse mutagenesis and archives. | 1.53e-05 | 9 | 200 | 3 | 16139793 | |
| Pubmed | 1.64e-05 | 251 | 200 | 9 | 29778605 | ||
| Pubmed | 1.96e-05 | 57 | 200 | 5 | 29089450 | ||
| Pubmed | 2.18e-05 | 10 | 200 | 3 | 25919494 | ||
| Pubmed | CDS1 ABCA2 GAK SALL3 KMT2B PCNX3 DBP CREBZF TBC1D1 KMT2A HDGFL2 DUSP8 PHRF1 ZNF768 UNC119 G3BP1 NUB1 SAMD14 | 2.31e-05 | 1006 | 200 | 18 | 15226823 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.49e-05 | 332 | 200 | 10 | 32786267 | |
| Pubmed | MAPT RREB1 SRCAP ZZEF1 HOXA10 PJA2 PML PHRF1 E2F2 CHAMP1 SP110 ZNF768 SIRT1 YEATS2 FIZ1 MACF1 CEP295 LZTS2 CEP170B | 2.68e-05 | 1116 | 200 | 19 | 31753913 | |
| Pubmed | 2.74e-05 | 268 | 200 | 9 | 33640491 | ||
| Pubmed | 3.19e-05 | 104 | 200 | 6 | 9205841 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 28800015 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 17550981 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 19062206 | ||
| Pubmed | N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor. | 3.29e-05 | 2 | 200 | 2 | 23724116 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 8453667 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 20140226 | ||
| Pubmed | Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. | 3.29e-05 | 2 | 200 | 2 | 10973990 | |
| Pubmed | A common motif targets huntingtin and the androgen receptor to the proteasome. | 3.29e-05 | 2 | 200 | 2 | 18586675 | |
| Pubmed | CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms. | 3.29e-05 | 2 | 200 | 2 | 31548309 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 17971449 | ||
| Pubmed | SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling. | 3.29e-05 | 2 | 200 | 2 | 25293974 | |
| Pubmed | Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease. | 3.29e-05 | 2 | 200 | 2 | 25205109 | |
| Pubmed | The Epigenetic Regulation of OLIG2 by Histone Demethylase KDM6B in Glioma Cells. | 3.29e-05 | 2 | 200 | 2 | 35132566 | |
| Pubmed | BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer. | 3.29e-05 | 2 | 200 | 2 | 34201956 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 27350136 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 37431882 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 28765952 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 3492492 | ||
| Pubmed | Isolation and characterization of murine Cds (CDP-diacylglycerol synthase) 1 and 2. | 3.29e-05 | 2 | 200 | 2 | 16023307 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 22733359 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 25632225 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 17110454 | ||
| Pubmed | Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA. | 3.29e-05 | 2 | 200 | 2 | 9407099 | |
| Pubmed | Tau Protein Modulates Perineuronal Extracellular Matrix Expression in the TauP301L-acan Mouse Model. | 3.29e-05 | 2 | 200 | 2 | 35454094 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 24973821 | ||
| Pubmed | Role of calcitonin gene-related peptide in functional adaptation of the skeleton. | 3.29e-05 | 2 | 200 | 2 | 25536054 | |
| Pubmed | Isolation and chromosomal localization of two human CDP-diacylglycerol synthase (CDS) genes. | 3.29e-05 | 2 | 200 | 2 | 9806839 | |
| Pubmed | CDP-diacylglycerol synthases regulate the growth of lipid droplets and adipocyte development. | 3.29e-05 | 2 | 200 | 2 | 26946540 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 23585566 | ||
| Pubmed | mTor mediates tau localization and secretion: Implication for Alzheimer's disease. | 3.29e-05 | 2 | 200 | 2 | 25791428 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 36691768 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 32467173 | ||
| Pubmed | Calcitonin Gene-Related Peptide Attenuates LPS-Induced Acute Kidney Injury by Regulating Sirt1. | 3.29e-05 | 2 | 200 | 2 | 32673294 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 36857168 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 17680780 | ||
| Pubmed | Mutant huntingtin alters Tau phosphorylation and subcellular distribution. | 3.29e-05 | 2 | 200 | 2 | 25143394 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 34440706 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 20417685 | ||
| Pubmed | Distinct properties of the two isoforms of CDP-diacylglycerol synthase. | 3.29e-05 | 2 | 200 | 2 | 25375833 | |
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 39067323 | ||
| Pubmed | 3.29e-05 | 2 | 200 | 2 | 26405034 | ||
| Pubmed | The BARD1 Cys557Ser variant and breast cancer risk in Iceland. | 3.29e-05 | 2 | 200 | 2 | 16768547 | |
| Pubmed | Rapid induction of gliogenesis in OLIG2 and NKX2.2-expressing progenitors-derived spheroids. | 3.29e-05 | 2 | 200 | 2 | 32716131 | |
| Pubmed | A tumorigenic MLL-homeobox network in human glioblastoma stem cells. | 3.29e-05 | 2 | 200 | 2 | 23108137 | |
| Pubmed | Roles of the HOXA10 gene during castrate-resistant prostate cancer progression. | 3.29e-05 | 2 | 200 | 2 | 30667363 | |
| Interaction | TOP3B interactions | ABCA2 HIVEP2 KMT2B PCNX3 OBSCN C15orf39 FYCO1 KDM6B BCL9 SRCAP ZZEF1 STK11IP CIC PPP1R26 TNRC18 SAFB ZNF276 NFKB2 PITX1 NAV1 LRRC56 DNMBP PLK3 CRYBG2 LMTK2 HUWE1 GTF2IRD1 ZNF865 SH2B2 PIKFYVE UNC119 NHSL1 RADIL IGF1R AATK G3BP1 MTOR KANK3 DUSP16 TNKS1BP1 SPEN CEP170B HTT SMAD7 TJP3 | 2.36e-12 | 1470 | 194 | 45 | int:TOP3B |
| Interaction | YWHAH interactions | ABCA2 SERBP1 HIVEP2 MAPT ANKRD27 CIC STIM1 HAUS8 PJA2 STARD9 TBC1D1 RECQL4 NAV1 KMT2A DNMBP DIP2B FOXO6 LMTK2 KLF15 HUWE1 AKT1S1 UNC119 NHSL1 RADIL FAM171A2 G3BP1 MTOR DUSP16 MACF1 TNKS1BP1 NUB1 CEP170B SNX2 HTT | 1.51e-09 | 1102 | 194 | 34 | int:YWHAH |
| Interaction | CBX3 interactions | ZHX3 KMT2B MAPT BARD1 RREB1 KDM6B CIC ZNF462 RECQL4 KMT2A HDGFL2 DUSP8 ZC3HC1 GTF2IRD1 CHAMP1 SP110 SIRT1 YEATS2 GTF2E1 UBE2O YJU2 MACF1 TNKS1BP1 SPEN | 1.61e-08 | 646 | 194 | 24 | int:CBX3 |
| Interaction | SEC13 interactions | TPR GAK SERBP1 MAPT TFG CIC ZNF276 RECQL4 SEC16B HUWE1 AR YJU2 HTT | 1.83e-07 | 216 | 194 | 13 | int:SEC13 |
| Interaction | YWHAG interactions | SERBP1 HIVEP2 MAPT CIC STIM1 HAUS8 PJA2 STARD9 TBC1D1 RECQL4 NAV1 KMT2A DNMBP FOXO6 LMTK2 HUWE1 AKT1S1 UNC119 NHSL1 RADIL IGF1R FAM171A2 MTOR ARHGEF1 DUSP16 MACF1 NUB1 LZTS2 CEP170B SNX2 HTT PSD4 | 3.54e-07 | 1248 | 194 | 32 | int:YWHAG |
| Interaction | BAG2 interactions | GAK MAP1B MAPT C15orf39 BCL3 RREB1 CIC RECQL4 MINDY4 PML SGTA FNBP4 HUWE1 ZFC3H1 SP110 YEATS2 TLE2 EIF4G2 QSER1 SPEN HTT | 6.53e-07 | 622 | 194 | 21 | int:BAG2 |
| Interaction | TLE3 interactions | HIVEP2 C15orf39 BCL9 CIC TNRC18 BRCA2 KMT2A NKX2-2 ANK3 AR SPTBN4 FAM193A TLE1 TLE2 TNKS1BP1 SPEN | 7.84e-07 | 376 | 194 | 16 | int:TLE3 |
| Interaction | CDK1 interactions | TPR SERBP1 MAPT BARD1 CIC SAFB BRCA2 RECQL4 PML RNF149 SAMHD1 HUWE1 AR SIRT1 AKAP12 GTF2E1 IGF1R AATK G3BP1 TLE1 | 1.15e-06 | 590 | 194 | 20 | int:CDK1 |
| Interaction | MAPK1 interactions | TPR SERBP1 MAPT BARD1 BCL3 RECQL4 PLCB1 NAV1 PLK3 PML DUSP8 RNF149 ZC3HC1 HUWE1 AR MTOR DUSP16 LZTS2 HTT | 1.36e-06 | 543 | 194 | 19 | int:MAPK1 |
| Interaction | LCK interactions | MAPT CISH STIM1 SAFB NAV1 DIP2B ANK3 SH3KBP1 LMTK2 TARS2 AR UNC119 FAM171A2 G3BP1 MACF1 TNKS1BP1 LZTS2 | 2.64e-06 | 463 | 194 | 17 | int:LCK |
| Interaction | DUSP16 interactions | KIF1A MAP1B HAUS8 BRCA2 NAV1 ZNHIT2 MAPK8IP1 DUSP8 ARHGEF1 DUSP16 CEP295 HTT | 3.37e-06 | 237 | 194 | 12 | int:DUSP16 |
| Interaction | MAP1LC3A interactions | SERBP1 MAP1B FYCO1 BCL9 SAFB TBC1D1 TRIM55 PML RAD23A ANK3 SIRT1 HTT | 4.01e-06 | 241 | 194 | 12 | int:MAP1LC3A |
| Interaction | TDG interactions | 4.48e-06 | 69 | 194 | 7 | int:TDG | |
| Interaction | PIN1 interactions | KMT2B MAPT GPR152 BARD1 TFG SSC5D PITX1 PML CHAMP1 ZNF768 AR ZBTB14 UNC119 G3BP1 TLE1 | 4.83e-06 | 383 | 194 | 15 | int:PIN1 |
| Interaction | PHF21A interactions | TPR KMT2B C15orf39 SOX8 RREB1 CIC BRCA2 NAV1 PML HUWE1 AR YEATS2 FAM193A TNKS1BP1 | 6.32e-06 | 343 | 194 | 14 | int:PHF21A |
| Interaction | EGR2 interactions | HIVEP2 C15orf39 SOX8 RREB1 BCL9 ZNF462 TNRC18 KMT2A TLE1 QSER1 | 6.39e-06 | 171 | 194 | 10 | int:EGR2 |
| Interaction | H3C3 interactions | ZHX3 KMT2B BARD1 RREB1 SRCAP CIC ZNF462 HOXA10 PITX1 KMT2A HDGFL2 RAD23A CHAMP1 GTF2E1 UBE2O QSER1 SPEN | 6.42e-06 | 495 | 194 | 17 | int:H3C3 |
| Interaction | MYO6 interactions | GAK MAPT APC2 RECQL4 FHIP1A PML RAD23A BMP2K LMTK2 AR YEATS2 UBE2O G3BP1 LZTS2 HTT | 7.67e-06 | 398 | 194 | 15 | int:MYO6 |
| Interaction | RUVBL2 interactions | SERBP1 MAP1B MAPT BCL3 SRCAP CIC ZNF462 BRCA2 RECQL4 MINDY4 ZNHIT2 RNF149 SMC4 HUWE1 AR YEATS2 UBE2O MTOR SNX2 | 8.41e-06 | 616 | 194 | 19 | int:RUVBL2 |
| Interaction | RBBP7 interactions | SERBP1 MAP1B MAPT CIC ZNF462 TNRC18 SAFB BRCA2 NFKB2 RECQL4 KMT2A RNF149 SMC4 HUWE1 SIRT1 UBE2O SPEN | 8.78e-06 | 507 | 194 | 17 | int:RBBP7 |
| Interaction | RBBP4 interactions | SERBP1 SALL3 ANKRD27 CIC ZNF462 TNRC18 SAFB RECQL4 KMT2A RNF149 SMC4 NOL9 HUWE1 CHAMP1 SIRT1 G3BP1 TLE1 SPEN | 1.15e-05 | 573 | 194 | 18 | int:RBBP4 |
| Interaction | GSK3A interactions | SERBP1 MAPT BCL3 TNRC18 NFKB2 SAMHD1 AR NHSL1 UBE2O FAM193A G3BP1 MACF1 TNKS1BP1 LZTS2 CEP170B SNX2 | 1.15e-05 | 464 | 194 | 16 | int:GSK3A |
| Interaction | NBN interactions | 1.16e-05 | 183 | 194 | 10 | int:NBN | |
| Interaction | PHF20 interactions | 1.16e-05 | 53 | 194 | 6 | int:PHF20 | |
| Interaction | HNF4A interactions | KMT2B RREB1 SRCAP CIC ZNF462 PML AR SIRT1 YEATS2 TLE1 QSER1 SPEN | 1.52e-05 | 275 | 194 | 12 | int:HNF4A |
| Interaction | USP9X interactions | SERBP1 MAP1B KDM6B BCL9 RECQL4 MINDY4 ZNHIT2 ANK3 SGTA LMTK2 HUWE1 IGF1R MTOR HTT PSD4 | 1.53e-05 | 422 | 194 | 15 | int:USP9X |
| Interaction | PSMC3 interactions | KIF1A MAP1B MAPT KDM6B RECQL4 PML RAD23A SMC4 TRIOBP KLF15 HUWE1 AR YEATS2 G3BP1 ARHGEF1 | 1.66e-05 | 425 | 194 | 15 | int:PSMC3 |
| Interaction | DNAJA1 interactions | MAP1B MAPT KDM6B CIC SAFB NFKB2 RECQL4 RNF149 HUWE1 AR UBE2O IGF1R AATK G3BP1 TLE2 LZTS2 HTT | 1.67e-05 | 533 | 194 | 17 | int:DNAJA1 |
| Interaction | PSMC5 interactions | SERBP1 MAP1B MAPT RECQL4 KMT2A PML RAD23A SMC4 SAMHD1 HUWE1 AR UBE2O IGF1R MTOR NUB1 HTT | 1.94e-05 | 484 | 194 | 16 | int:PSMC5 |
| Interaction | DNAJA2 interactions | GAK MAP1B KDM6B CIC PJA2 SAFB RECQL4 SGTA NOL9 HUWE1 TARS2 UBE2O IGF1R TLE2 DUSP16 LZTS2 HTT | 2.07e-05 | 542 | 194 | 17 | int:DNAJA2 |
| Interaction | GSC interactions | 2.10e-05 | 87 | 194 | 7 | int:GSC | |
| Interaction | PSMD2 interactions | SERBP1 MAP1B MAPT RECQL4 PML RAD23A SMC4 SAMHD1 HUWE1 AR UNC119 UBE2O G3BP1 NUB1 HTT | 2.18e-05 | 435 | 194 | 15 | int:PSMD2 |
| Interaction | DYNC1H1 interactions | TPR SERBP1 MAP1B MAPT BRCA2 HUWE1 ZFC3H1 AR SIRT1 AKAP12 UBE2O AATK G3BP1 DUSP16 TNKS1BP1 HTT | 2.31e-05 | 491 | 194 | 16 | int:DYNC1H1 |
| Interaction | PARP1 interactions | GAK MAPT BARD1 NCK1 RREB1 SRCAP CIC BRCA2 STARD9 RECQL4 HDGFL2 PML RAD23A TCEA2 SMC4 LMTK2 SAMHD1 NOL9 HUWE1 AR SIRT1 GTF2E1 UBE2O YJU2 MTOR TLE1 RNF146 EIF4G2 SNX2 | 2.48e-05 | 1316 | 194 | 29 | int:PARP1 |
| Interaction | RCOR1 interactions | TPR KMT2B C15orf39 BCL3 SOX8 RREB1 CIC BRCA2 RECQL4 SMC4 HUWE1 AR YEATS2 FAM193A TNKS1BP1 SPEN | 2.48e-05 | 494 | 194 | 16 | int:RCOR1 |
| Interaction | YWHAZ interactions | SERBP1 HIVEP2 MAPT BARD1 TFG ANKRD27 CIC STIM1 STARD9 TBC1D1 RECQL4 NAV1 KMT2A DNMBP PML HUWE1 AKT1S1 AR NHSL1 RADIL IGF1R FAM171A2 MTOR DUSP16 MACF1 NUB1 CEP170B HTT PSD4 | 2.59e-05 | 1319 | 194 | 29 | int:YWHAZ |
| Interaction | YWHAE interactions | SERBP1 HIVEP2 MAP1B MAPT ANKRD27 CIC STIM1 TBC1D1 RECQL4 NAV1 KMT2A MINDY4 DNMBP RAD23A ZC3HC1 HUWE1 AKT1S1 RADIL UBE2O IGF1R G3BP1 MTOR DUSP16 MACF1 NUB1 CEP170B HTT PSD4 | 2.83e-05 | 1256 | 194 | 28 | int:YWHAE |
| Interaction | FEV interactions | KMT2B C15orf39 RREB1 BCL9 CIC ZNF462 KMT2A ZBTB14 TLE1 QSER1 | 2.84e-05 | 203 | 194 | 10 | int:FEV |
| Interaction | BARHL1 interactions | 2.99e-05 | 7 | 194 | 3 | int:BARHL1 | |
| Interaction | HSPA4L interactions | SERBP1 MAPT TFG CIC RECQL4 SGTA RNF149 HUWE1 IGF1R AATK ARHGEF1 | 3.21e-05 | 250 | 194 | 11 | int:HSPA4L |
| Interaction | LANCL2 interactions | 3.24e-05 | 93 | 194 | 7 | int:LANCL2 | |
| Interaction | PFN1 interactions | TPR SERBP1 NCK1 RECQL4 NAV1 DNMBP ZNF541 RNF149 AR UNC119 NHSL1 TLE1 ARHGEF1 MACF1 TNKS1BP1 HTT | 3.56e-05 | 509 | 194 | 16 | int:PFN1 |
| Interaction | MORF4L2 interactions | 3.74e-05 | 168 | 194 | 9 | int:MORF4L2 | |
| Interaction | H3-3A interactions | ZHX3 KMT2B MAPT BARD1 RREB1 KDM6B SRCAP CIC HOXA10 PITX1 KMT2A HDGFL2 PML CHAMP1 AR SIRT1 GTF2E1 QSER1 SPEN SNX2 | 3.85e-05 | 749 | 194 | 20 | int:H3-3A |
| Interaction | SLC25A11 interactions | SERBP1 MAP1B MAPT CIC RECQL4 SH3KBP1 LMTK2 HUWE1 AATK G3BP1 HTT | 3.85e-05 | 255 | 194 | 11 | int:SLC25A11 |
| Interaction | CTBP1 interactions | SERBP1 MAPT C15orf39 BCL3 RREB1 CIC RECQL4 PLCB1 KMT2A AR YEATS2 IGF1R SPEN HTT | 4.12e-05 | 406 | 194 | 14 | int:CTBP1 |
| Interaction | USP5 interactions | 4.28e-05 | 213 | 194 | 10 | int:USP5 | |
| Interaction | YWHAB interactions | SERBP1 MAPT CIC STIM1 STARD9 TBC1D1 RECQL4 NAV1 KMT2A DNMBP FOXO6 SGTA AKT1S1 NHSL1 RADIL IGF1R FAM171A2 G3BP1 MTOR DUSP16 MACF1 NUB1 CEP170B HTT | 4.40e-05 | 1014 | 194 | 24 | int:YWHAB |
| Interaction | H2BC8 interactions | ZHX3 KMT2B CDS2 BARD1 RREB1 SRCAP KMT2A HDGFL2 MRPS18B ZC3HC1 NOL9 CHAMP1 ZNF768 UBE2O YJU2 QSER1 SPEN | 4.45e-05 | 576 | 194 | 17 | int:H2BC8 |
| Interaction | KAT5 interactions | TPR BARD1 BCL3 SRCAP FCHO1 RECQL4 PML FOXO6 AR SIRT1 ZBTB14 YJU2 LZTS2 | 4.61e-05 | 358 | 194 | 13 | int:KAT5 |
| Interaction | PIAS4 interactions | 4.70e-05 | 173 | 194 | 9 | int:PIAS4 | |
| Interaction | NTPCR interactions | 5.25e-05 | 136 | 194 | 8 | int:NTPCR | |
| Interaction | YAP1 interactions | TPR SERBP1 KMT2B APC2 NCK1 SRCAP TNRC18 KMT2A PML ANK3 FNBP4 SMC4 TRIOBP KLF15 HUWE1 CHAMP1 AR SIRT1 UBE2O IGF1R TNKS1BP1 LZTS2 SPEN SNX2 SMAD7 | 5.41e-05 | 1095 | 194 | 25 | int:YAP1 |
| Interaction | ASH2L interactions | KMT2B BARD1 KDM6B SRCAP BRCA2 RECQL4 KMT2A AR UNC119 YEATS2 HTT | 5.46e-05 | 265 | 194 | 11 | int:ASH2L |
| Interaction | SP1 interactions | GAK KIF1A SOX8 BRCA2 NFKB2 RECQL4 KMT2A PML E2F2 GTF2IRD1 AR SPEN HTT | 5.62e-05 | 365 | 194 | 13 | int:SP1 |
| Interaction | RAD50 interactions | BARD1 NCK1 CIC BRCA2 RECQL4 MINDY4 PML HUWE1 CHAMP1 AR UBE2O CD6 TLE1 | 6.63e-05 | 371 | 194 | 13 | int:RAD50 |
| Interaction | YWHAQ interactions | TPR SERBP1 HIVEP2 MAPT CIC STARD9 TBC1D1 RECQL4 NAV1 KMT2A DNMBP FOXO6 AKT1S1 AR NHSL1 IGF1R FAM171A2 G3BP1 MTOR DUSP16 MACF1 NUB1 CEP170B SNX2 HTT | 7.55e-05 | 1118 | 194 | 25 | int:YWHAQ |
| Interaction | GTF2H1 interactions | 7.96e-05 | 107 | 194 | 7 | int:GTF2H1 | |
| Interaction | CUL4A interactions | TPR MAP1B OBSCN BCL3 TFG STIM1 PJA2 FIG4 NFKB2 RECQL4 SEC16B ANK3 SAMHD1 SIRT1 G3BP1 MTOR TLE1 TLE2 TNKS1BP1 NUB1 SMAD7 | 7.98e-05 | 854 | 194 | 21 | int:CUL4A |
| Interaction | MAPRE3 interactions | 8.14e-05 | 230 | 194 | 10 | int:MAPRE3 | |
| Interaction | PDIA6 interactions | ZHX3 SERBP1 KDM6B CIC SAFB RECQL4 KMT2A SH3KBP1 RNF149 HUWE1 UBE2O MACF1 | 8.20e-05 | 327 | 194 | 12 | int:PDIA6 |
| Interaction | HSPA4 interactions | SERBP1 MAP1B MAPT BARD1 BCL3 BRCA2 RECQL4 DNMBP SGTA HUWE1 AR SIRT1 G3BP1 MTOR TLE1 CEP295 NUB1 HTT | 8.35e-05 | 667 | 194 | 18 | int:HSPA4 |
| Interaction | MTHFD1 interactions | SERBP1 MAP1B MAPT RECQL4 PML SGTA RNF149 HUWE1 UNC119 G3BP1 HTT | 8.65e-05 | 279 | 194 | 11 | int:MTHFD1 |
| Interaction | BUB3 interactions | 8.74e-05 | 232 | 194 | 10 | int:BUB3 | |
| Interaction | PTGES3 interactions | SERBP1 KIF1A MAPT BRCA2 FIG4 RECQL4 ZNHIT2 DIP2B DUSP8 NOL9 AR G3BP1 DUSP16 HTT | 9.06e-05 | 437 | 194 | 14 | int:PTGES3 |
| Interaction | XRCC6 interactions | TPR SERBP1 MAP1B DSCR4 BARD1 CIC TNRC18 BRCA2 RECQL4 KMT2A HDGFL2 PHRF1 SAMHD1 HUWE1 CHAMP1 AR GTF2E1 UBE2O RNF146 SPEN HTT SMAD7 | 9.13e-05 | 928 | 194 | 22 | int:XRCC6 |
| Interaction | SMC5 interactions | TPR ZHX3 SERBP1 SALL3 MAP1B RREB1 CIC PRAM1 SAFB BRCA2 KMT2A HDGFL2 PML TCEA2 SGTA FNBP4 CHAMP1 YEATS2 RADIL G3BP1 EIF4G2 QSER1 SPEN | 9.86e-05 | 1000 | 194 | 23 | int:SMC5 |
| Interaction | KDM1A interactions | TPR KMT2B MAPT C15orf39 FYCO1 BCL3 SOX8 RREB1 CIC ZNF462 BRCA2 RECQL4 NAV1 HUWE1 CHAMP1 AR UNC119 YEATS2 FAM193A FIZ1 TNKS1BP1 HTT | 1.12e-04 | 941 | 194 | 22 | int:KDM1A |
| Interaction | USP2 interactions | 1.12e-04 | 239 | 194 | 10 | int:USP2 | |
| Interaction | TBR1 interactions | 1.12e-04 | 113 | 194 | 7 | int:TBR1 | |
| Interaction | GTF3C4 interactions | 1.18e-04 | 195 | 194 | 9 | int:GTF3C4 | |
| Interaction | CSNK2B interactions | ZHX3 KMT2B KDM6B CIC RECQL4 KMT2A HDGFL2 PML SH3KBP1 PHRF1 SP110 AR SIRT1 UBE2O TLE1 SNX2 TJP3 | 1.20e-04 | 625 | 194 | 17 | int:CSNK2B |
| Interaction | PRPF19 interactions | CIC PJA2 RECQL4 TRIM55 MINDY4 ZNHIT2 PHRF1 FNBP4 HUWE1 AR AKAP12 UBE2O YJU2 TLE2 | 1.23e-04 | 450 | 194 | 14 | int:PRPF19 |
| Interaction | FHL2 interactions | TNRC18 PRDM11 TRIM55 PML BMP2K E2F2 AR SIRT1 YEATS2 TNKS1BP1 QSER1 SPEN HTT | 1.27e-04 | 396 | 194 | 13 | int:FHL2 |
| Interaction | TCOF1 interactions | SERBP1 MAP1B OBSCN ZZEF1 ZNF462 RECQL4 MINDY4 ZNHIT2 HDGFL2 SIRT1 FAM193A | 1.29e-04 | 292 | 194 | 11 | int:TCOF1 |
| Interaction | SFN interactions | SERBP1 MAP1B MAPT HAUS8 PJA2 RECQL4 NAV1 KMT2A DNMBP LMTK2 IGF1R FAM171A2 G3BP1 MTOR MACF1 NUB1 CEP170B HTT | 1.32e-04 | 692 | 194 | 18 | int:SFN |
| Interaction | AHCY interactions | 1.33e-04 | 293 | 194 | 11 | int:AHCY | |
| Interaction | CSNK2A1 interactions | SERBP1 KMT2B MAPT FCHO1 CIC SAFB RECQL4 KMT2A HDGFL2 PML SH3KBP1 PHRF1 FNBP4 ZFC3H1 AR SIRT1 UBE2O CD6 EIF4G2 MACF1 TNKS1BP1 HTT | 1.40e-04 | 956 | 194 | 22 | int:CSNK2A1 |
| Interaction | MAGED1 interactions | 1.41e-04 | 295 | 194 | 11 | int:MAGED1 | |
| Interaction | SLC16A1 interactions | 1.43e-04 | 200 | 194 | 9 | int:SLC16A1 | |
| Interaction | EIF3F interactions | SERBP1 MAP1B MAPT CIC RECQL4 PML ANK3 HUWE1 G3BP1 MTOR EIF4G2 | 1.46e-04 | 296 | 194 | 11 | int:EIF3F |
| Interaction | XRCC5 interactions | TPR SERBP1 BARD1 ZZEF1 CIC SAFB BRCA2 RECQL4 DNMBP RAD23A PHRF1 SAMHD1 HUWE1 AR RNF146 | 1.46e-04 | 515 | 194 | 15 | int:XRCC5 |
| Interaction | EIF2S2 interactions | 1.46e-04 | 247 | 194 | 10 | int:EIF2S2 | |
| Interaction | RUVBL1 interactions | MAP1B MAPT BCL3 SRCAP CIC RECQL4 KMT2A ZNHIT2 RNF149 SMC4 HUWE1 AR UBE2O IGF1R MTOR HTT | 1.48e-04 | 575 | 194 | 16 | int:RUVBL1 |
| Interaction | POLR1E interactions | RREB1 SRCAP ZNF462 BRCA2 NFKB2 KMT2A NOL9 ZFC3H1 SIRT1 GTF2E1 CD6 LZTS2 | 1.55e-04 | 350 | 194 | 12 | int:POLR1E |
| Interaction | ASF1A interactions | 1.56e-04 | 249 | 194 | 10 | int:ASF1A | |
| Interaction | KPNA2 interactions | SERBP1 MAP1B CIC ARHGAP22 NFKB2 RECQL4 SMC4 SAMHD1 HUWE1 GTF2IRD1 AR SIRT1 UBE2O G3BP1 LZTS2 | 1.59e-04 | 519 | 194 | 15 | int:KPNA2 |
| Interaction | CHEK2 interactions | 1.61e-04 | 250 | 194 | 10 | int:CHEK2 | |
| Interaction | CEBPA interactions | ZHX3 KMT2B C15orf39 SOX8 DBP RREB1 BCL9 CIC PRAM1 TNRC18 SAFB PITX1 KMT2A HDGFL2 PML RAD23A SMC4 SP110 AR SIRT1 YEATS2 G3BP1 EIF4G2 MACF1 QSER1 SPEN | 1.62e-04 | 1245 | 194 | 26 | int:CEBPA |
| Interaction | DAXX interactions | SERBP1 ARHGAP22 TNRC18 BRCA2 HDGFL2 PML CHAMP1 AR UBE2O CD6 MACF1 SPEN | 1.68e-04 | 353 | 194 | 12 | int:DAXX |
| Interaction | PTPN4 interactions | 1.69e-04 | 54 | 194 | 5 | int:PTPN4 | |
| Interaction | TEX19 interactions | 1.69e-04 | 54 | 194 | 5 | int:TEX19 | |
| Interaction | HDAC1 interactions | TPR ZHX3 KMT2B C15orf39 BCL3 SOX8 RREB1 CIC TNRC18 BRCA2 RECQL4 NAV1 KMT2A NKX2-2 PML SMC4 AR SIRT1 YEATS2 G3BP1 TLE1 TNKS1BP1 SPEN SMAD7 | 1.72e-04 | 1108 | 194 | 24 | int:HDAC1 |
| Interaction | KDM6A interactions | 1.78e-04 | 162 | 194 | 8 | int:KDM6A | |
| Interaction | EWSR1 interactions | ZHX3 SERBP1 MAPT BARD1 C15orf39 BCL9 TFG CIC SAFB BRCA2 RECQL4 PITX1 KMT2A HDGFL2 RAD23A MRPS18B PHRF1 FNBP4 ZNF768 SIRT1 GTF2E1 | 1.81e-04 | 906 | 194 | 21 | int:EWSR1 |
| Interaction | KANSL3 interactions | 1.83e-04 | 86 | 194 | 6 | int:KANSL3 | |
| Interaction | SEC24C interactions | 1.85e-04 | 207 | 194 | 9 | int:SEC24C | |
| Interaction | SQSTM1 interactions | MAP1B MAPT PJA2 TRIM55 NAV1 PML RAD23A DIP2B BMP2K MRPS18B SMC4 KLF15 NOL9 HUWE1 AKT1S1 AR YEATS2 FAM193A G3BP1 MTOR ARHGEF1 EIF4G2 TNKS1BP1 NUB1 LZTS2 HTT | 1.89e-04 | 1257 | 194 | 26 | int:SQSTM1 |
| Interaction | CIRBP interactions | 1.94e-04 | 164 | 194 | 8 | int:CIRBP | |
| Interaction | KAT2B interactions | 1.96e-04 | 256 | 194 | 10 | int:KAT2B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | APC2 DENND1C FCHO1 HAUS8 PRAM1 SAFB HDGFL2 RAD23A SGTA MUC16 RFX2 YJU2 TLE2 KANK3 TJP3 | 2.60e-06 | 797 | 200 | 15 | chr19p13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | KMT2B LRFN3 BCL3 DBP ANKRD27 CIC SSC5D PPP1R37 EXOC3L2 NCR1 ZNF541 ZNF865 AKT1S1 SPTBN4 ZBTB45 ARHGEF1 FIZ1 | 2.12e-05 | 1192 | 200 | 17 | chr19q13 |
| Cytoband | 19p13.3 | 8.78e-05 | 237 | 200 | 7 | 19p13.3 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.39e-05 | 181 | 140 | 8 | 694 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | SCRT2 ZHX3 HIVEP2 SALL3 RREB1 ZNF462 ZNF276 ZNF319 ZNF541 KLF15 CHAMP1 ZNF865 ZNF768 ZBTB14 ZBTB45 FIZ1 | 1.41e-04 | 718 | 140 | 16 | 28 |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 3.54e-04 | 4 | 140 | 2 | 1332 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B | C15orf39 BCL9 STK11IP CISH NKX2-8 NFKB2 NCR1 PLK3 MAPK8IP1 BMP2K MRPS18B GTF2IRD1 AKT1S1 IGF1R OLIG2 SMAD7 TJP3 | 1.36e-06 | 554 | 200 | 17 | M2244 |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 3.42e-06 | 200 | 200 | 10 | M9439 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ABCA2 SERBP1 MAP1B MAPT FYCO1 SOX8 DBP SRCAP STK11IP SSC5D NFKB2 NAV1 PLK3 SEC16B ANK3 FAM13C DUSP8 TAMALIN NHSL1 AATK FAM193A GRAMD2B CEP295 HTT | 4.00e-06 | 1102 | 200 | 24 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ABCA2 SERBP1 MAP1B MAPT FYCO1 SOX8 DBP SRCAP STK11IP SSC5D NFKB2 NAV1 PLK3 SEC16B ANK3 FAM13C DUSP8 TAMALIN NHSL1 AATK FAM193A GRAMD2B CEP295 HTT | 5.58e-06 | 1124 | 200 | 24 | MM1070 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | PCNX3 KDM6B BCL9 ZNF462 PPP1R37 NAV1 RAD23A TRIOBP ZBTB14 PIKFYVE FAM171A2 TNKS1BP1 LZTS2 CEP170B | 1.55e-05 | 467 | 200 | 14 | M1347 |
| Coexpression | GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN | 2.09e-05 | 196 | 200 | 9 | M4404 | |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | ABCA2 KIF1A SOX8 NACAD STIM1 ARHGAP22 ACAN TMEM184B MAPK8IP1 DIP2B ANK3 FAM13C SH3KBP1 CHAMP1 AATK LZTS2 OLIG2 SMAD7 | 2.10e-05 | 754 | 200 | 18 | M39037 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | PCNX3 KDM6B BCL9 ZNF462 PPP1R37 NAV1 RAD23A TRIOBP ZBTB14 PIKFYVE FAM171A2 TNKS1BP1 LZTS2 CEP170B | 2.30e-05 | 484 | 200 | 14 | MM999 |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP | 2.46e-05 | 200 | 200 | 9 | M3842 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN | 2.46e-05 | 200 | 200 | 9 | M7915 | |
| Coexpression | GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 2.46e-05 | 200 | 200 | 9 | M6563 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 HIVEP2 MAP1B CDS2 BARD1 NCK1 ZZEF1 PJA2 BRCA2 DNMBP BMP2K PIKFYVE IGF1R FAM193A TLE1 MACF1 SPEN SNX2 SMAD7 | 3.33e-05 | 856 | 200 | 19 | M4500 |
| Coexpression | MARTENS_BOUND_BY_PML_RARA_FUSION | TPR HIVEP2 CDS2 C15orf39 BCL3 ZZEF1 CISH RNF149 TARS2 RFX2 UBE2O YJU2 OLIG2 | 5.25e-05 | 456 | 200 | 13 | M2094 |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 6.77e-05 | 177 | 200 | 8 | M9401 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | ABCA2 KIF1A MAP1B MAPT APC2 FCHO1 NAV1 TCEA2 MAPK8IP1 ANK3 GTF2IRD1 MYO16 BAALC | 1.04e-04 | 488 | 200 | 13 | M39104 |
| Coexpression | JNK_DN.V1_DN | 1.11e-04 | 190 | 200 | 8 | M2745 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ZHX3 HIVEP2 KIF1A MAP1B MAPT BCL9 PJA2 HPS4 PLCB1 NKX2-2 SUSD4 RPH3AL RETREG2 MRPS18B HUWE1 PIKFYVE IGF1R G3BP1 SMAD7 | 1.24e-04 | 946 | 200 | 19 | M39169 |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 1.47e-04 | 198 | 200 | 8 | M9407 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP | 1.53e-04 | 199 | 200 | 8 | M8115 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN | 1.53e-04 | 199 | 200 | 8 | M3583 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_BCELL_DN | 1.58e-04 | 200 | 200 | 8 | M8261 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN | 1.58e-04 | 200 | 200 | 8 | M7323 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN | 1.58e-04 | 200 | 200 | 8 | M8506 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN | 1.58e-04 | 200 | 200 | 8 | M6091 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN | 1.58e-04 | 200 | 200 | 8 | M4015 | |
| Coexpression | GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN | 1.58e-04 | 200 | 200 | 8 | M6580 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN | 1.74e-04 | 68 | 200 | 5 | MM803 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN | 1.86e-04 | 69 | 200 | 5 | M19523 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.97e-06 | 51 | 199 | 6 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | KIF1A MAP1B APC2 BCL3 FNDC1 PRDM11 ZNF276 TBC1D1 PITX1 PLCB1 NAV1 PLK3 MAPK8IP1 CRYBG2 SUSD4 ANK3 EMB SP110 AKT1S1 MACF1 OLIG2 CEP170B SMAD7 PSD4 | 1.80e-05 | 984 | 199 | 24 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | TPR ABCA2 SERBP1 KIF1A MAP1B APC2 C8orf34 PPP1R26 ZNF462 NKX2-8 FNDC1 BRCA2 PLK3 MAPK8IP1 RPH3AL EMB RNF149 SMC4 E2F2 AATK TLE2 MACF1 OLIG2 BAALC | 1.86e-05 | 986 | 199 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | TPR APC2 BCL3 BCL9 ZNF462 FNDC1 PRDM11 ZNF276 BRCA2 PITX1 PLCB1 NAV1 SMC4 PODXL2 GTF2IRD1 SP110 AKT1S1 SPTBN4 AATK MACF1 QSER1 CEP170B PSD4 | 4.78e-05 | 978 | 199 | 23 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TPR ABCA2 TMEM229A KIF1A MAP1B MAPT FYCO1 DENND1C SOX8 BCL9 TFG STK11IP ZNF462 ARHGAP22 BRCA2 RECQL4 PLK3 MAPK8IP1 CALCA EMB DUSP8 SMC4 SIRT1 EIF4G2 MACF1 CEP295 QSER1 SAMD14 TJP3 | 5.72e-05 | 1414 | 199 | 29 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.37e-07 | 193 | 200 | 9 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-07 | 196 | 200 | 9 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.61e-06 | 180 | 200 | 8 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-06 | 181 | 200 | 8 | 61c6e000db7047fda4b4bb5024f3af24577e7d29 | |
| ToppCell | Neuronal_cells-Schwann_cells|World / Lineage and Cell class | 2.32e-06 | 189 | 200 | 8 | 371cdc92549269e45c23c5a5b3cae9c5d35ee217 | |
| ToppCell | Neuronal_cells|World / Lineage and Cell class | 2.32e-06 | 189 | 200 | 8 | 3948775a0ebd4b32c1623d5487f5581e6e2934d7 | |
| ToppCell | COVID-19_Mild-MAIT|COVID-19_Mild / Disease condition and Cell class | 2.51e-06 | 191 | 200 | 8 | e834d7a6aa7bb4f194b203d351e53bf5d95175d6 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.60e-06 | 192 | 200 | 8 | 3e2a0f332e7f9833ba88f3c809cee78b65090401 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.92e-06 | 195 | 200 | 8 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-06 | 199 | 200 | 8 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-06 | 199 | 200 | 8 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-06 | 199 | 200 | 8 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-06 | 199 | 200 | 8 | 94baf00dad27964392c3fc34970a4e79d576d0d3 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-06 | 199 | 200 | 8 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | facs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.40e-06 | 199 | 200 | 8 | c11e0044d3cc37f6bb26df033ad4448b419addfc | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-06 | 199 | 200 | 8 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.52e-06 | 200 | 200 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 200 | 200 | 8 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 150 | 200 | 7 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.78e-06 | 159 | 200 | 7 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-06 | 165 | 200 | 7 | 7f293f64e7df7710b13016937cdd4f1af326f8c3 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.03e-05 | 166 | 200 | 7 | b041010038a570ad929812f35514cb54e4f68f66 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 166 | 200 | 7 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 169 | 200 | 7 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 172 | 200 | 7 | 33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 1.35e-05 | 173 | 200 | 7 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 173 | 200 | 7 | 23e50492bc673aff9df95d97f0b9be4ce57cbf01 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 174 | 200 | 7 | 6ca9433d398aa3b48ecdc522dd545119e7c77dd4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 174 | 200 | 7 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 177 | 200 | 7 | 9d2d70d53b919fed3328812889a55e5e1a0759de | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-05 | 177 | 200 | 7 | 13f22e578728be477b097889af483b1e3f3e18bb | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 178 | 200 | 7 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-05 | 178 | 200 | 7 | 934a2a7b35a23b56e34d4d0ef68c271513ef1fe9 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.68e-05 | 179 | 200 | 7 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.68e-05 | 179 | 200 | 7 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-05 | 180 | 200 | 7 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 180 | 200 | 7 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 1.81e-05 | 181 | 200 | 7 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.94e-05 | 183 | 200 | 7 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 185 | 200 | 7 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 185 | 200 | 7 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 2.23e-05 | 187 | 200 | 7 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | COVID-NK-|COVID / Condition, Cell_class and T cell subcluster | 2.30e-05 | 188 | 200 | 7 | fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1 | |
| ToppCell | COVID-NK|COVID / Condition, Cell_class and T cell subcluster | 2.30e-05 | 188 | 200 | 7 | 0beaa671611110a11e46156f54f5202cc24967a4 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 189 | 200 | 7 | 16a4c92dd7a0d60f3691bd3130a091a9a54730f1 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 190 | 200 | 7 | 55be54c39ac9eb8e2c1515d8c212130ce2b0ef88 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 190 | 200 | 7 | 24b78a6f2a763acb8f4e90a5d245c9c77605b426 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 2.64e-05 | 192 | 200 | 7 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 192 | 200 | 7 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 2.73e-05 | 193 | 200 | 7 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|World / disease group, cell group and cell class | 2.73e-05 | 193 | 200 | 7 | c2a2a2c14a7085690262db5c2a70e38db67dee18 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.73e-05 | 193 | 200 | 7 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 194 | 200 | 7 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | HSPCs-Mk_prog.|World / Lineage and Cell class | 2.82e-05 | 194 | 200 | 7 | 5049f4f102844d766eca577e809cf21f7908a9d2 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.91e-05 | 195 | 200 | 7 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | mild_COVID-19-MAIT|World / disease group, cell group and cell class (v2) | 2.91e-05 | 195 | 200 | 7 | 74f0f709d9b3eed5d7e02a51884f02cc281782f1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-05 | 195 | 200 | 7 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 2.91e-05 | 195 | 200 | 7 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.91e-05 | 195 | 200 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 3.01e-05 | 196 | 200 | 7 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_CTL|Influenza_Severe / Disease, condition lineage and cell class | 3.11e-05 | 197 | 200 | 7 | 8610307434d99e6411a5a6c6769094e9a0749d4d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-05 | 198 | 200 | 7 | 3550798bfb9a426f3b28538a9778159bec2480d0 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.21e-05 | 198 | 200 | 7 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.21e-05 | 198 | 200 | 7 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 198 | 200 | 7 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 198 | 200 | 7 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 198 | 200 | 7 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 3.21e-05 | 198 | 200 | 7 | 6333e46cd1ccf5841ce15aea98a4b2f5e3ae4675 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.21e-05 | 198 | 200 | 7 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 3.31e-05 | 199 | 200 | 7 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.42e-05 | 200 | 200 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.42e-05 | 200 | 200 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.42e-05 | 200 | 200 | 7 | 979258173b82f37aeaaedd53b4a527da1dbe1b80 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-MAIT|COVID-19_Mild / Disease, condition lineage and cell class | 3.42e-05 | 200 | 200 | 7 | 45b2a84d5a325f551205ae31c164d2de7773d3b6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 200 | 200 | 7 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.42e-05 | 200 | 200 | 7 | 38e681997913fcbc93f4e1715820e53844376eab | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 200 | 200 | 7 | e5b4821fff40566c4a7dc3f74a14e27eb06b165d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-05 | 147 | 200 | 6 | 5e6dd2ddc67b3722f6528e7277cbc7f296098687 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.80e-05 | 149 | 200 | 6 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.02e-05 | 150 | 200 | 6 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 6.24e-05 | 151 | 200 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type | 6.71e-05 | 153 | 200 | 6 | b24c693b142206d13b29c96faa7f79a1a22bc2ef | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.48e-05 | 156 | 200 | 6 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.48e-05 | 156 | 200 | 6 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.75e-05 | 157 | 200 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-05 | 159 | 200 | 6 | c960df9e4fa980401941866b5081facac4590b4d | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 160 | 200 | 6 | 0fee84844733d36805e1df90ca09478169746708 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 160 | 200 | 6 | 5c68d6a76c59e3a7e668ae5471396478a55756ac | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.60e-05 | 160 | 200 | 6 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.21e-05 | 162 | 200 | 6 | b877b232f0a879a9058d81ad4730e7846484b7c3 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.21e-05 | 162 | 200 | 6 | 59f6a9005c4f22f084c25ea36f3cacce5144a9ae | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.21e-05 | 162 | 200 | 6 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.21e-05 | 162 | 200 | 6 | 7384a4dd38ed68ca02a72df6deff4d34c9694ce1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.21e-05 | 162 | 200 | 6 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | Control-APC-like-Monocytes|Control / group, cell type (main and fine annotations) | 9.52e-05 | 163 | 200 | 6 | 4bc80a2c741d462724b6f3902377d48c57478932 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-mature_NK_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 164 | 200 | 6 | 22f37c39fdce2cf6dc72c6db619537d4b0234839 | |
| ToppCell | Influenza_Severe-CD4+_CTL|Influenza_Severe / Disease group and Cell class | 9.85e-05 | 164 | 200 | 6 | 9ffd40ae1f39290840bea79fa4e73cb7e009f310 | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 9.85e-05 | 164 | 200 | 6 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 1.02e-04 | 165 | 200 | 6 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 167 | 200 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | SPAG8 SRCAP ZZEF1 CIC ACAN ANK3 HUWE1 SP110 IGF1R CD6 ARHGEF1 | 1.30e-06 | 195 | 200 | 11 | 4991_UP |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.44e-06 | 197 | 200 | 11 | 7283_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HG-U133A | ZHX3 HIVEP2 BCL9 HOXA10 ACAN PPP1R37 TCEA2 SUSD4 ANK3 UBE2O AATK | 1.59e-06 | 199 | 200 | 11 | 348_DN |
| Drug | NSC-364372 | TPR APC2 ZNF276 ACAN NFKB2 RECQL4 PML SGTA DUSP8 AR SIRT1 MTOR DUSP16 LZTS2 HTT TJP3 | 6.39e-06 | 484 | 200 | 16 | CID000435143 |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 8.46e-06 | 193 | 200 | 10 | 4202_DN | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | MAP1B C15orf39 NFKB2 PLCB1 BMP2K HUWE1 ZNF768 LPA QSER1 PSD4 | 8.46e-06 | 193 | 200 | 10 | 950_UP |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | KIF1A MAP1B LRFN3 CREBZF HPS4 NFKB2 PLCB1 PODXL2 SP110 ZNF768 | 9.26e-06 | 195 | 200 | 10 | 1532_DN |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A | ZHX3 HIVEP2 MAP1B SRCAP NFKB2 PITX1 KCNS1 CRYBG2 BMP2K LMTK2 | 1.01e-05 | 197 | 200 | 10 | 3692_DN |
| Drug | nocodazole; Down 200; 1uM; MCF7; HG-U133A | 1.06e-05 | 198 | 200 | 10 | 621_DN | |
| Drug | Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.06e-05 | 198 | 200 | 10 | 2901_UP | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.06e-05 | 198 | 200 | 10 | 6104_DN | |
| Drug | Ethamivan [304-84-7]; Down 200; 18uM; MCF7; HT_HG-U133A | ABCA2 HIVEP2 MAP1B ZZEF1 CREBZF CISH ZNHIT2 PML SMC4 ARHGEF1 | 1.06e-05 | 198 | 200 | 10 | 2879_DN |
| Drug | Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; HL60; HT_HG-U133A | C15orf39 SPAG8 CREBZF HOXA10 ZNF276 KCNS1 ZNF768 CD6 MTOR SNX2 | 1.06e-05 | 198 | 200 | 10 | 2150_UP |
| Drug | Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.11e-05 | 199 | 200 | 10 | 3574_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.11e-05 | 199 | 200 | 10 | 7439_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | ABCA2 HIVEP2 C15orf39 KDM6B HPS4 RPH3AL BMP2K SP110 ZNF768 CEP170B | 1.11e-05 | 199 | 200 | 10 | 1648_DN |
| Drug | cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A | 1.16e-05 | 200 | 200 | 10 | 383_UP | |
| Drug | Methamphetamine | SCRT2 PCNX3 MAPT CDS2 OBSCN BARD1 DBP SPAG8 KDM6B ZZEF1 STK11IP CIC STIM1 ITM2A PLK3 ZNF541 TECPR1 PHRF1 AR FAM193A SLC12A3 MTOR TLE2 ARHGEF1 KANK3 PROX2 EIF4G2 MACF1 LZTS2 | 1.50e-05 | 1401 | 200 | 29 | ctd:D008694 |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.47e-05 | 182 | 200 | 9 | 848_UP | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.06e-05 | 191 | 200 | 9 | 5210_DN | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.27e-05 | 192 | 200 | 9 | 5990_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 5.27e-05 | 192 | 200 | 9 | 5596_DN | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.27e-05 | 192 | 200 | 9 | 6013_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 5.71e-05 | 194 | 200 | 9 | 1239_UP | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 5.71e-05 | 194 | 200 | 9 | 1804_DN | |
| Drug | lomustine; Down 200; 100uM; MCF7; HT_HG-U133A | 5.71e-05 | 194 | 200 | 9 | 7089_DN | |
| Drug | BAS 012416453; Down 200; 38uM; PC3; HT_HG-U133A | 5.71e-05 | 194 | 200 | 9 | 6876_DN | |
| Drug | diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A | 5.94e-05 | 195 | 200 | 9 | 333_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.94e-05 | 195 | 200 | 9 | 2852_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.94e-05 | 195 | 200 | 9 | 953_DN | |
| Drug | D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 6782_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 4752_DN | |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 5345_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 5765_DN | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 1301_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 4227_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 2755_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 1684_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; PC3; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 4195_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 2848_DN | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 5689_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 4787_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; HL60; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 2468_UP | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 6732_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 3277_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 5782_UP | |
| Drug | paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A | 6.68e-05 | 198 | 200 | 9 | 640_UP | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 6358_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A | C15orf39 DBP ARHGAP22 KCNS1 PML PODXL2 ZNF768 ARHGEF1 GRAMD2B | 6.68e-05 | 198 | 200 | 9 | 3666_DN |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; PC3; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 6726_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 6016_DN | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; PC3; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 6716_UP | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; HL60; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 2918_UP | |
| Drug | Rolipram [61413-54-5]; Down 200; 14.6uM; PC3; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 6730_DN | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 2882_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 3995_UP | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 4351_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; HL60; HG-U133A | 6.68e-05 | 198 | 200 | 9 | 1601_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 2069_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; HL60; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 2549_UP | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A | 6.95e-05 | 199 | 200 | 9 | 6410_UP | |
| Drug | 3-nitropropionic acid; Up 200; 10uM; PC3; HT_HG-U133A | 6.95e-05 | 199 | 200 | 9 | 6407_UP | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 6.95e-05 | 199 | 200 | 9 | 5617_DN | |
| Drug | Enilconazole [35554-44-0]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.95e-05 | 199 | 200 | 9 | 5538_UP | |
| Drug | genistein; Up 200; 1uM; MCF7; HG-U133A | 6.95e-05 | 199 | 200 | 9 | 267_UP | |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 6.95e-05 | 199 | 200 | 9 | 7418_UP | |
| Drug | Felbinac [5728-52-9]; Down 200; 18.8uM; PC3; HT_HG-U133A | 7.22e-05 | 200 | 200 | 9 | 4639_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 7.22e-05 | 200 | 200 | 9 | 5488_DN | |
| Drug | tert-butylcatechol | 7.66e-05 | 10 | 200 | 3 | CID000077643 | |
| Drug | 6a-i | 7.68e-05 | 2 | 200 | 2 | CID000081423 | |
| Drug | 1-Behenyl-2-lauryl-sn-glycero-3-phosphocholine | 7.68e-05 | 2 | 200 | 2 | CID000129220 | |
| Drug | Pe v | 1.04e-04 | 164 | 200 | 8 | CID005326793 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.23e-04 | 168 | 200 | 8 | 3395_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.34e-04 | 170 | 200 | 8 | 4153_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.40e-04 | 171 | 200 | 8 | 1000_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.57e-04 | 174 | 200 | 8 | 1659_DN | |
| Drug | DMAB | 1.78e-04 | 133 | 200 | 7 | CID000006053 | |
| Drug | 3-methyladenine | 1.86e-04 | 134 | 200 | 7 | CID000001673 | |
| Drug | Amino Acids | 1.94e-04 | 33 | 200 | 4 | ctd:D000596 | |
| Drug | NSC71948 | 2.23e-04 | 138 | 200 | 7 | CID000415676 | |
| Drug | PP242 | 2.29e-04 | 3 | 200 | 2 | ctd:C572919 | |
| Drug | alpha-eudesmol | 2.29e-04 | 3 | 200 | 2 | CID000092762 | |
| Drug | AC1L2OFV | 2.29e-04 | 3 | 200 | 2 | CID000100273 | |
| Drug | beta-cubebene | 2.29e-04 | 3 | 200 | 2 | CID000093081 | |
| Drug | 11p111 | 2.29e-04 | 3 | 200 | 2 | CID002767782 | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; PC3; HT_HG-U133A | 2.67e-04 | 188 | 200 | 8 | 5733_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.86e-04 | 190 | 200 | 8 | 5579_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 2.86e-04 | 190 | 200 | 8 | 5786_UP | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 2.97e-04 | 191 | 200 | 8 | 1227_UP | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; PC3; HT_HG-U133A | 2.97e-04 | 191 | 200 | 8 | 6658_DN | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.07e-04 | 192 | 200 | 8 | 6213_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.07e-04 | 192 | 200 | 8 | 4104_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; HL60; HT_HG-U133A | 3.18e-04 | 193 | 200 | 8 | 1864_UP | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.18e-04 | 193 | 200 | 8 | 6749_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.18e-04 | 193 | 200 | 8 | 1644_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 3.18e-04 | 193 | 200 | 8 | 3908_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.18e-04 | 193 | 200 | 8 | 7008_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 3.18e-04 | 193 | 200 | 8 | 4321_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.18e-04 | 193 | 200 | 8 | 4443_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.18e-04 | 193 | 200 | 8 | 4241_DN | |
| Disease | Malignant neoplasm of breast | CDS1 APC2 OBSCN BARD1 CIC BRCA2 PLCB1 ZNHIT2 ZNF541 RNF149 RFX2 SP110 AR SIRT1 AKAP12 IGF1R MTOR MACF1 FCRL5 LZTS2 SPEN | 1.14e-05 | 1074 | 197 | 21 | C0006142 |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.98e-05 | 57 | 197 | 5 | DOID:10652 (implicated_via_orthology) | |
| Disease | Intellectual Disability | HIVEP2 MAP1B APC2 KDM6B TFG CIC ZNF462 CALCA CHAMP1 MTOR MACF1 HTT | 5.14e-05 | 447 | 197 | 12 | C3714756 |
| Disease | sexual dimorphism measurement | HIVEP2 KMT2B KIF1A BCL3 ZZEF1 ZNF462 PRAM1 SSC5D ACAN PITX1 DIP2B SEC16B FOXO6 SAMHD1 GTF2IRD1 IGF1R SLC12A3 LPA KANK3 MACF1 | 5.58e-05 | 1106 | 197 | 20 | EFO_0021796 |
| Disease | cancer (implicated_via_orthology) | 8.53e-05 | 268 | 197 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | prostate adenocarcinoma (implicated_via_orthology) | 1.32e-04 | 3 | 197 | 2 | DOID:2526 (implicated_via_orthology) | |
| Disease | response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head | 2.64e-04 | 4 | 197 | 2 | EFO_0020976, EFO_1001930, MONDO_0007915 | |
| Disease | neutrophil count | HIVEP2 MAPT NCK1 RREB1 KDM6B BCL9 FCHO1 CIC PLCB1 EXOC3L2 RETREG2 EMB ZC3HC1 E2F2 TARS2 SIRT1 AKAP12 AATK FCRL5 SNX2 HTT | 3.96e-04 | 1382 | 197 | 21 | EFO_0004833 |
| Disease | body surface area | KIF1A RREB1 ZNF462 ACAN C12orf42 SEC16B SAMHD1 IGF1R AATK MTOR MACF1 SMAD7 PSD4 | 4.13e-04 | 643 | 197 | 13 | EFO_0022196 |
| Disease | coronary atherosclerosis measurement | 4.38e-04 | 5 | 197 | 2 | EFO_0007938 | |
| Disease | IGF-1 measurement | ZHX3 NCK1 RREB1 SRCAP PRSS36 ZNF462 STARD9 PITX1 TCEA2 LPA RNF146 | 4.71e-04 | 488 | 197 | 11 | EFO_0004627 |
| Disease | C-reactive protein measurement | AHI1-DT BCL3 RREB1 ZZEF1 ZNF276 TBC1D1 PPP1R37 EXOC3L2 SEC16B ANK3 KLF15 YEATS2 RADIL LPA RNF146 MACF1 TNKS1BP1 QSER1 PSD4 | 4.89e-04 | 1206 | 197 | 19 | EFO_0004458 |
| Disease | cortical thickness | ZHX3 KMT2B MAPT RREB1 ZNF462 NAV1 KMT2A MIEF2 DIP2B TRIOBP ZC3HC1 NHSL1 IGF1R G3BP1 PROX2 MACF1 QSER1 MYO16 | 5.09e-04 | 1113 | 197 | 18 | EFO_0004840 |
| Disease | acute lymphoblastic leukemia (implicated_via_orthology) | 6.54e-04 | 6 | 197 | 2 | DOID:9952 (implicated_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 6.73e-04 | 157 | 197 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | eosinophil count | HIVEP2 MAPT BCL3 KDM6B NACAD CISH FNDC1 TBC1D1 EXOC3L2 ZNF319 TCEA2 DIP2B EMB SMC4 ZC3HC1 E2F2 FAM193A TNKS1BP1 OLIG2 MYO16 SMAD7 | 1.02e-03 | 1488 | 197 | 21 | EFO_0004842 |
| Disease | osteoporosis (is_implicated_in) | 1.15e-03 | 31 | 197 | 3 | DOID:11476 (is_implicated_in) | |
| Disease | serum gamma-glutamyl transferase measurement | PCNX3 NCK1 RREB1 FCHO1 KMT2A DNMBP SEC16B LMTK2 TRIOBP KLF15 E2F2 ZNF768 IGF1R LZTS2 TJP3 | 1.29e-03 | 914 | 197 | 15 | EFO_0004532 |
| Disease | family history of Alzheimer’s disease | 1.32e-03 | 71 | 197 | 4 | EFO_0009268 | |
| Disease | Malignant tumor of prostate | 1.55e-03 | 9 | 197 | 2 | cv:C0376358 | |
| Disease | parental longevity | 1.89e-03 | 494 | 197 | 10 | EFO_0007796 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 1.93e-03 | 10 | 197 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | tauopathy (implicated_via_orthology) | 1.93e-03 | 10 | 197 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding) | 1.93e-03 | 10 | 197 | 2 | C1834752 | |
| Disease | Mycobacterium tuberculosis, susceptibility to | 1.93e-03 | 10 | 197 | 2 | cv:C1834752 | |
| Disease | MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO | 1.93e-03 | 10 | 197 | 2 | 607948 | |
| Disease | interventricular septum thickness | 1.93e-03 | 10 | 197 | 2 | EFO_0009287 | |
| Disease | Varicose veins | 1.94e-03 | 193 | 197 | 6 | HP_0002619 | |
| Disease | neuroimaging measurement | ZHX3 KMT2B MAP1B MAPT RREB1 ZNF462 ARHGAP22 DIP2B ANK3 NHSL1 G3BP1 ARHGEF1 MACF1 QSER1 MYO16 HTT | 2.29e-03 | 1069 | 197 | 16 | EFO_0004346 |
| Disease | testosterone measurement | ZHX3 MAPT RREB1 KDM6B SRCAP PLCB1 DNMBP DIP2B ANK3 FNBP4 ZC3HC1 GTF2IRD1 CHAMP1 AR DUSP16 MACF1 TNKS1BP1 MYO16 | 2.33e-03 | 1275 | 197 | 18 | EFO_0004908 |
| Disease | Combined immunodeficiency | 2.59e-03 | 41 | 197 | 3 | C0494261 | |
| Disease | bipolar I disorder | 2.62e-03 | 141 | 197 | 5 | EFO_0009963 | |
| Disease | aortic stenosis, aortic valve calcification | 2.78e-03 | 42 | 197 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | uric acid measurement | ZHX3 PCNX3 RREB1 ZNF276 NAV1 MINDY4 EXOC3L2 LMTK2 KLF15 AR IGF1R | 2.79e-03 | 610 | 197 | 11 | EFO_0004761 |
| Disease | dementia (is_implicated_in) | 2.80e-03 | 12 | 197 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.28e-03 | 91 | 197 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | Respiratory Depression | 3.30e-03 | 13 | 197 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 3.30e-03 | 13 | 197 | 2 | C0035229 | |
| Disease | Respiratory Failure | 3.30e-03 | 13 | 197 | 2 | C1145670 | |
| Disease | sphingomyelin 18:1 measurement | 3.30e-03 | 13 | 197 | 2 | EFO_0010394 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 3.30e-03 | 13 | 197 | 2 | C0270914 | |
| Disease | obesity (implicated_via_orthology) | 3.32e-03 | 215 | 197 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 3.38e-03 | 45 | 197 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | atrial fibrillation | 3.62e-03 | 371 | 197 | 8 | EFO_0000275 | |
| Disease | waist-hip ratio | ZHX3 DSCR4 MAPT RREB1 ZZEF1 C8orf34 HAUS8 SSC5D MINDY4 PML TCEA2 SEC16B ANK3 YEATS2 IGF1R RNF146 HTT | 3.67e-03 | 1226 | 197 | 17 | EFO_0004343 |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.71e-03 | 220 | 197 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | daytime rest measurement | 3.81e-03 | 295 | 197 | 7 | EFO_0007828 | |
| Disease | nephroblastoma (is_implicated_in) | 3.83e-03 | 14 | 197 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 3.83e-03 | 14 | 197 | 2 | C0677776 | |
| Disease | Paroxysmal atrial fibrillation | 4.04e-03 | 156 | 197 | 5 | C0235480 | |
| Disease | prostate cancer (is_marker_for) | 4.04e-03 | 156 | 197 | 5 | DOID:10283 (is_marker_for) | |
| Disease | familial atrial fibrillation | 4.04e-03 | 156 | 197 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.04e-03 | 156 | 197 | 5 | C2585653 | |
| Disease | response to irinotecan | 4.40e-03 | 15 | 197 | 2 | EFO_0004829 | |
| Disease | employment status | 4.40e-03 | 15 | 197 | 2 | EFO_0005241 | |
| Disease | Atrial Fibrillation | 4.49e-03 | 160 | 197 | 5 | C0004238 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 4.56e-03 | 50 | 197 | 3 | EFO_0022247 | |
| Disease | platelet component distribution width | HIVEP2 NCK1 ZZEF1 STIM1 PLCB1 EXOC3L2 BMP2K RFX2 UBE2O IGF1R G3BP1 MACF1 | 5.00e-03 | 755 | 197 | 12 | EFO_0007984 |
| Disease | Congenital total cataract | 5.00e-03 | 16 | 197 | 2 | C0266539 | |
| Disease | visceral adipose tissue measurement | 5.24e-03 | 481 | 197 | 9 | EFO_0004765 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 5.24e-03 | 166 | 197 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 5.65e-03 | 17 | 197 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | ovarian cancer (is_implicated_in) | 6.27e-03 | 56 | 197 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Bone marrow hypocellularity | 6.32e-03 | 18 | 197 | 2 | C1855710 | |
| Disease | Schizophrenia | AHI1-DT BCL9 HPS4 PLCB1 NAV1 KMT2A PML ANK3 RETREG2 SIRT1 MTOR OLIG2 MYO16 | 6.62e-03 | 883 | 197 | 13 | C0036341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APFRSALESSPADPA | 26 | P06881 | |
| PPESEPAREASASAL | 146 | Q2M3D2 | |
| RSSDEENGPPSSPDL | 201 | Q96B36 | |
| APPESTDEGAETESP | 361 | Q92888 | |
| DSRTDSDIPEIPPSS | 51 | Q92903 | |
| EFVSPSPPADVSERA | 181 | Q99728 | |
| PSPEPDRLSGSSSDS | 391 | Q9NQ75 | |
| APFRSALESSPDPAT | 26 | P10092 | |
| GPSAEAAPDTTADPA | 31 | Q02952 | |
| AAPDTTADPAIAASD | 36 | Q02952 | |
| SSPSPDSPDAAPEAR | 436 | Q13202 | |
| DSERAPASVPETPTA | 21 | O95870 | |
| SDLAVSNISPPSPDS | 186 | Q49A92 | |
| TASDSESRAESAPLP | 31 | O95674 | |
| PASAAAPTTPDGAEE | 271 | Q8IU99 | |
| NSESSPSRCPSDPDS | 1426 | Q6XZF7 | |
| ASALSDSSSPDTPPR | 41 | P0C7V0 | |
| SCTADTRSDSPDPAP | 166 | Q9NSE2 | |
| EPRIFTPDSDAASPA | 11 | P56555 | |
| STPRPPEDALSGDSD | 941 | Q9Y4F5 | |
| TSQPLDPSSDPSSLE | 731 | Q8IV53 | |
| DPSSDPSSLEDPRAR | 736 | Q8IV53 | |
| ESDFESDPPSPKSSE | 741 | Q9NSY1 | |
| PPSSNETPAVSDSKE | 571 | P78312 | |
| SAPPEASPTAAPESS | 86 | P54725 | |
| TSSSDDEEFEPPAPF | 1521 | Q2KHR3 | |
| PEDSLSPPATSPSDS | 541 | Q9Y5A7 | |
| AALAEESPPAPSSRS | 951 | Q96JH8 | |
| ESPPAPSSRSSSTED | 956 | Q96JH8 | |
| QAPPPEDSDSGSDSD | 471 | P30203 | |
| ESSEEPLAPSDPFSL | 121 | Q96NW4 | |
| SSASAPDVDDPEAFP | 391 | Q8NC51 | |
| PDEDPLGSRTSASSP | 321 | Q9NZ53 | |
| PSPFSSSSPENVEDS | 461 | O14526 | |
| VLDASAEPETSSPPS | 7436 | Q8WXI7 | |
| PASEPESEPELESAS | 91 | Q5SY16 | |
| SESAPSQTDSDVPPE | 2151 | P46821 | |
| INEDFRTESPPSPSS | 91 | Q9BRK4 | |
| RTESPPSPSSDVEDA | 96 | Q9BRK4 | |
| PSSSEDTSDPRNVPA | 96 | A2A368 | |
| NTSLAPEDPTFPADT | 216 | O76036 | |
| VPDSASPADDSFVDP | 86 | P16333 | |
| TCSPASDESPLTPLE | 1501 | Q9Y6X6 | |
| DAAEPTSAFLPPTES | 291 | Q9UQF2 | |
| SSLPETPTETDSLDP | 1296 | Q9BQS8 | |
| LSASSSLEPTPPEDT | 406 | Q9NQG7 | |
| SATDPADPVDTAEPA | 931 | O15054 | |
| ESVPLDPSASSSSLP | 1301 | P08069 | |
| SRSEPSPDAPESPSS | 1456 | Q5SYE7 | |
| DPSLASTDSSEPSPL | 206 | Q9H6A9 | |
| PASDPARSPSDSDSQ | 881 | Q96RD9 | |
| APERSPDDSSPSAPA | 206 | A8MYZ6 | |
| PPDTSSASEDEGSLR | 141 | Q9P265 | |
| SPESTDSSPERDFPL | 1291 | Q9P1Y6 | |
| TSPAASVPTSEEPAS | 1216 | O94854 | |
| APAASSVPSPCDEAS | 416 | Q8TDT2 | |
| EAEPSSTALRTTDPP | 376 | Q96QE4 | |
| DSLSAPFPASEPSLE | 981 | Q8IWU2 | |
| SDTPSSVDPCPDEIS | 171 | Q96KK3 | |
| SGEASSSEEEPPSPD | 2386 | Q9UMN6 | |
| RDGDPDALTPPSAAS | 401 | Q9BTN0 | |
| APPDEDDSAAPSTLS | 151 | P10275 | |
| ELSPAPSESSKASPE | 301 | P31260 | |
| ESSLETSPPDSSQRP | 56 | O15522 | |
| PSEDFSSSSQAEVPP | 386 | Q9BT25 | |
| AATPDPAARTPDSEV | 16 | Q7Z6J2 | |
| PPSDETDSSSAPSKE | 786 | P78344 | |
| AQPPEDSSPPASSES | 2911 | Q7Z6Z7 | |
| RGPPSSSDSEPEAEL | 391 | Q7Z4V5 | |
| SATEVPSASEEPSPS | 776 | P16112 | |
| APSPAPSPDSDSDSD | 496 | O75864 | |
| PPRLALSEDTEPSSS | 721 | A8MVW0 | |
| AEASERSTEAPAPPA | 6836 | Q5VST9 | |
| ERSSSPPELDRDSPF | 26 | Q3B8N5 | |
| LDPNSSDSPPRDLDA | 366 | Q5K4E3 | |
| ATTLDPSSASAPPET | 266 | Q8TAX7 | |
| LDSANDLPRSPTSPS | 11 | Q9Y2I7 | |
| PEAEPTDSDSPPSSS | 771 | O14976 | |
| SSASSLSEPEPSEPP | 1581 | O95996 | |
| PTADPSEPSADSYLT | 576 | Q711Q0 | |
| APESNSELASPAPEA | 721 | Q05DH4 | |
| EEEADAPAPSSPPTS | 2641 | P42858 | |
| GRTSDPNPAAPDSES | 2936 | P42858 | |
| DSPSEEPLPSTSTLC | 311 | Q14209 | |
| SSEAPPYNSEPAEES | 36 | P51587 | |
| PPPPSEEAVSSSSED | 746 | Q92562 | |
| SASSPESPVLAASPE | 241 | Q96JM3 | |
| ETAPEDAQKSSSPAP | 221 | Q13283 | |
| AEEDSSASAPPSRLS | 706 | Q4ZHG4 | |
| TVASSDDDSPPARSP | 1031 | O00512 | |
| PLSPPCADSATSEAA | 336 | Q9BY84 | |
| DPDALPAPSSSVDRV | 701 | Q8N1P7 | |
| RAPDSDTASSPDSSP | 136 | B7Z1M9 | |
| APSDSPASPDEDLQA | 1596 | Q9BZC7 | |
| SPVPPGADVSDSSDD | 3306 | Q12955 | |
| PDPSTEASSEEAPTE | 1146 | P08519 | |
| TDSDAPPSAAAPDSG | 31 | Q8WXS3 | |
| IDVPVPSFSDSDPAA | 126 | O43736 | |
| APAPAAAAEPSEDTL | 316 | Q96SL8 | |
| ESPAEAPSLTQESSP | 416 | Q6NY19 | |
| PSPVSEDDSDASSPC | 36 | Q9UIH9 | |
| TEESIPSRSSPEGPD | 1676 | Q03164 | |
| TSRDTPSPVDPDTVE | 186 | Q10586 | |
| AARPSSADGSAPDSP | 26 | Q6PCB8 | |
| PASPPEDTSAEVSRA | 446 | Q9UHL9 | |
| TAQSPTPSVEADSPD | 46 | Q96HH9 | |
| PDPSPDRSANTSPES | 371 | P20749 | |
| PLEPHPDFDLSSSSS | 2081 | Q9C0D2 | |
| EPSPASSPSERAESE | 96 | Q9BXA9 | |
| RPVPEALSPAFSEDS | 1406 | Q12756 | |
| SEAESTENSPTPSPL | 1851 | P42345 | |
| PTEPAEREPRSSETS | 181 | Q9UNE2 | |
| LAPSSSAPEGPAETD | 96 | Q96C03 | |
| EEIATPDSSAPSSPK | 1241 | Q8NEY1 | |
| PADPREPLENSASES | 36 | P78337 | |
| SETSESDDDSPPRPA | 356 | P29083 | |
| PGSDRPPSSQSDDST | 381 | Q9BW92 | |
| ASISEPSDTDPEPRT | 386 | Q8N1F8 | |
| ESSPSSPEPASLPAE | 36 | O60749 | |
| SPEPASLPAEDISAN | 41 | O60749 | |
| EPFPSSDDSPRSALA | 31 | Q99932 | |
| AAPEEYSDPESPQSS | 76 | Q9NQ03 | |
| RSPARTPPSEEDSAE | 76 | O43765 | |
| PPTRRDSGSSQSDDP | 516 | A6NKL6 | |
| PEPLSTAEAPAESAT | 36 | B2RXF0 | |
| DVLAPDPASPTTAAA | 6 | Q9Y519 | |
| SSALASSEDLQPPSP | 281 | Q8WV15 | |
| DDSPRTPSNTPSAEA | 16 | Q9Y3Z3 | |
| DTEPDSTAAVPSQPA | 36 | Q8N3X1 | |
| APSPPATADQDDDSD | 551 | Q6ZMQ8 | |
| SEEASAPDAPDALPD | 811 | Q6ZMQ8 | |
| DPAASTSTPEPDPAD | 361 | Q8IYG6 | |
| TSTPEPDPADSSDFL | 366 | Q8IYG6 | |
| SSDGPTSLPASDEDP | 406 | P48378 | |
| SSESLPAAAEEAPEP | 61 | O94761 | |
| SPSPSPTERAPASEE | 36 | P29590 | |
| SPAEASLASDPHELP | 426 | Q9NQV5 | |
| DDSSPSPKGRDEAPS | 516 | Q96QH2 | |
| ASSPEPSSPESESRG | 441 | Q8NDX1 | |
| PDVSASSPEEPHSDS | 126 | Q8NC44 | |
| LSSPDIFDSPSPEED | 501 | Q96B97 | |
| EDSSSPERTSPPDSS | 536 | Q96EB6 | |
| SPATPSPDASTSLED | 231 | Q9NTX7 | |
| AEPHSEDDSRDASPP | 161 | Q8IZD0 | |
| PQDSSSKSPEPSADE | 96 | O95096 | |
| SKSPEPSADESPDND | 101 | O95096 | |
| SLVSSRPSSPEPDDL | 6 | Q13516 | |
| SSTPSDCPPELSAEL | 41 | Q13516 | |
| EERAPDPPAHSTSSA | 396 | Q5T8A7 | |
| EDSDSDAPPSPAGSE | 26 | P57073 | |
| SVSDAFLPPSSQPEE | 3836 | Q9P2P6 | |
| PEPSSSGEETPDAAL | 381 | Q8NE31 | |
| EPSSSSVPSAPEEEE | 2216 | Q6ZRS2 | |
| LTSEATSDAPDTSPP | 1036 | A1L4H1 | |
| SDEILSESPSPSDPV | 166 | Q9HB58 | |
| EPPEPSFDTVARDAS | 696 | E7EW31 | |
| LDSSRSHSPSSPDPD | 611 | Q13586 | |
| GSDPTSSPDSATPDD | 131 | Q9H2D6 | |
| SSEELAEAPTEAPSP | 331 | Q15424 | |
| AEAPTEAPSPEARDS | 336 | Q15424 | |
| GASNSEPSEPDSPTR | 576 | Q7Z5H3 | |
| APFRSALESSPADPA | 26 | P01258 | |
| NSTDLDSAPEDPTSP | 1396 | Q96RK0 | |
| EFRSSPAPSSETDEA | 126 | Q96LP6 | |
| PEATTEPDSATAEPD | 521 | Q6ZRI6 | |
| EPDSATAEPDSAPAT | 526 | Q6ZRI6 | |
| DSSSPVDRPEPEAAS | 356 | Q86WB0 | |
| SDDEAAPAPTAGPSA | 2681 | O15417 | |
| APVSLVETAPEDSSP | 396 | Q9H4B4 | |
| DDGSDDSSPPSASPA | 351 | Q8NC42 | |
| DSSPPSASPAESEPQ | 356 | Q8NC42 | |
| APSEEDSLSSVPISP | 36 | Q9Y676 | |
| DSPSDDTVEGTPPSQ | 171 | O43829 | |
| PTADCPDAVPSSAET | 221 | O15105 | |
| DVSNEDPSSPRASPA | 251 | Q04724 | |
| PDPPTTDSEKAAAAA | 496 | P0CJ78 | |
| SETPVPAAAETADPL | 426 | Q9BYV6 | |
| TAAADSACEEPPAPT | 246 | Q96K62 | |
| PPAESESGSESEPDA | 31 | Q13432 | |
| PRDPSEDTPAVDGST | 306 | Q4G0A6 | |
| EAATESSRPPVNAPD | 2276 | Q96T58 | |
| SSEPPAPASSPEAAS | 1126 | Q92766 | |
| PSAPAEDRSGTPDSI | 196 | Q92734 | |
| DESDLPSTSQDPPSS | 2296 | P12270 | |
| PSDTDASSEVERPGP | 411 | Q7Z6L1 | |
| PPRSSSSDPDFVVVD | 356 | Q5VX71 | |
| PPSPITEASEAAEAA | 496 | Q9C0C2 | |
| SDSESHLPEEPAPLS | 571 | Q86TI0 | |
| SSSPEPPAVAELSDS | 1166 | Q9C0C9 | |
| APRSPESDSQSPEFE | 101 | Q9H5H4 | |
| TLPSTDVAQPPSDSD | 301 | Q8N554 | |
| ESPEPAATCSLPSDL | 21 | Q9NS37 | |
| ASSDAEPEPPSGRTE | 26 | Q9NTJ3 | |
| LSSDEPSPPAAYDSS | 26 | P55017 | |
| ALPAAPEDAAETPAT | 2206 | Q9H254 | |
| PEDAAETPATPAAAE | 2211 | Q9H254 | |
| DRDVDESSPQDSPPS | 221 | P10636 | |
| ASPEPDAAAAPRTAE | 156 | O14492 | |
| SDSEDEAAPSPLQPA | 211 | Q9BW85 | |
| ETPSEAPSEARTTPA | 846 | Q9NQ66 | |
| DSPDPESPDDSESDS | 126 | O00193 | |
| DSPDSEETPRASSPH | 936 | Q96JE7 | |
| PAVSDSDSSPLEDIS | 281 | O95049 | |
| EAAEPATTAAPSLPA | 171 | Q9P2F9 | |
| TPPDSVKDASAAEPA | 161 | Q9UHR6 | |
| ADVSPATAEEPLSPS | 1506 | O43149 | |
| PSSLPLENETDSHPS | 636 | Q96JM2 | |
| LPTSSRDASEAPDPS | 96 | Q15560 | |
| PSPSETCDSEISEAP | 831 | P31629 | |
| EPRVPEASSEPFDTS | 931 | Q9H4I2 | |
| SASPSPPESLVEEER | 191 | Q04725 | |
| AVIEASAAPSSEPDP | 681 | O43164 | |
| AFKPEETSSNSDPPS | 641 | O60293 | |
| PQSSESDISDAPPSL | 341 | Q9ULM3 | |
| AAPSLDPSRNPDISS | 661 | Q9H0D2 | |
| PEPPSSESSLSADSS | 271 | O15069 | |
| SGEEAAEPSAPSRTP | 416 | Q00653 | |
| PSPPTSDSDSDSEGP | 706 | Q00653 |